EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Modulating mutational outcomes and improving precise gene editing at CRISPR-Cas9-induced breaks by chemical inhibition of end-joining pathways

Joost Schimmel, Núria Muñoz-Subirana, Hanneke Kool, Robin van Schendel, Sven van der Vlies, Juliette A Kamp, Femke M S de Vrij, Steven A Kushner, Graeme C M Smith, Simon J Boulton, Marcel Tijsterman

Cell Reports · 2023-02 · 42 (2) · 112019

DOI: 10.1016/j.celrep.2023.112019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2023-02. Verfasst von Joost Schimmel und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands. Hauptthemen laut MEDLINE: Gene Editing, CRISPR-Cas Systems. Die Arbeit wurde bisher 79-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, European Research Council, The Francis Crick Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gene EditingCRISPR-Cas SystemsDNA Breaks, Double-StrandedMutationDNA End-Joining Repair

Stichwörter der Autor:innen

CP: Molecular biologyCRISPR/Cas9HDRNHEJTMEJdouble-strand breaksend-joininggene editing

Autor:innen und Institutionen

  • Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands.
  • Department of Psychiatry, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Department of Psychiatry, Erasmus Medical Center, Rotterdam, the Netherlands; Department of Psychiatry, Columbia University Irving Medical Center, New York, NY, USA.
  • Artios Pharma, The Glenn Berge Building, Babraham Research Campus, Cambridge, UK.
  • Artios Pharma, The Glenn Berge Building, Babraham Research Campus, Cambridge, UK; The Francis Crick Institute, London, UK.
  • Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands; Institute of Biology Leiden, Leiden University, Sylviusweg 72, 2333 BE Leiden, the Netherlands. Electronic address: m.tijsterman@l…

Förderung

  • Wellcome Trust
  • European Research Council
  • The Francis Crick Institute
  • KWF Kankerbestrijding

Zitieren

APA

Schimmel, J., Muñoz-Subirana, N., Kool, H., van Schendel, R., van der Vlies, S., Kamp, J. A., de Vrij, F. M. S., Kushner, S. A., Smith, G. C. M., Boulton, S. J., & Tijsterman, M. (2023). Modulating mutational outcomes and improving precise gene editing at CRISPR-Cas9-induced breaks by chemical inhibition of end-joining pathways. Cell Reports, 42(2), 112019. https://doi.org/10.1016/j.celrep.2023.112019

Vancouver

Schimmel J, Muñoz-Subirana N, Kool H, van Schendel R, van der Vlies S, Kamp JA, et al. Modulating mutational outcomes and improving precise gene editing at CRISPR-Cas9-induced breaks by chemical inhibition of end-joining pathways. Cell Reports. 2023;42(2):112019. doi:10.1016/j.celrep.2023.112019

BibTeX
@article{Schimmel2023,
  author = {Schimmel, Joost and Muñoz-Subirana, Núria and Kool, Hanneke and van Schendel, Robin and van der Vlies, Sven and Kamp, Juliette A and de Vrij, Femke M S and Kushner, Steven A and Smith, Graeme C M and Boulton, Simon J and Tijsterman, Marcel},
  title = {Modulating mutational outcomes and improving precise gene editing at CRISPR-Cas9-induced breaks by chemical inhibition of end-joining pathways},
  journal = {Cell Reports},
  year = {2023},
  volume = {42},
  number = {2},
  pages = {112019},
  doi = {10.1016/j.celrep.2023.112019}
}
Kostenlos starten →